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Assessing the impact of renal artery clamping
during laparoscopic partial nephrectomy (LPN) for
small renal masses: the rationale and design of
the CLamp vs Off Clamp Kidney during LPN
(CLOCK II) randomised phase III trial
Dear Editor,
Interplay between patient- and surgery-related factors
determines the functional recovery after partial nephrectomy
(PN) [1]. Ischaemic injury resulting from renal arterial
clamping has historically been one of the major
modifiable surgical factors responsible for the functional
decline after PN. As such, several techniques for
minimising or even eliminating hilar clamping have been
described [2].
Laparoscopic PN (LPN) with a pure off-clamp technique has
been described, but the debate is still ongoing as to whether
it is appropriate and beneficial with respect to safety and
renal function [3]. The indication to perform an off-clamp
LPN has remained mostly subjective. When opted for, the
off-clamp resection is attempted to eventually clamp the
artery ‘on demand’ in cases of bleeding. This behaviour
has undoubtedly compromised the quality of the published
data.
With the aim of raising the level of evidence, the CLamp vs
Off Clamp Kidney during LPN (CLOCK II) randomised
clinical trial was conceived. The CLOCK II is a pre–
postoperative, prospective, multicentre, parallel, superiority,
randomised controlled trial (RCT), supported by the Italian
Group for Advanced Laparo-Endoscopic surgery (AGILE
group, www.agilegroup.it).
Here we report the rationale and design of the study, a large,
phase III RCT seeking to examine the role of renal artery
clamping during pure LPN for small renal masses
(ClinicalTrials.gov NCT02287987). The Standard Protocol
Items: Recommendations for Interventional Trials (SPIRIT)
guidelines were followed [4].
The primary aim of the study is to compare the preoperative
vs postoperative (at 3 and 6 months) GFR in on-clamp vs
off-clamp LPN. The secondary aim is to compare the
treatment groups: (i) in terms of technical difficulties, namely
the cross-over rate from off-clamp to on-clamp, the time
taken for renorrhaphy, and the total operative time; (ii) in
terms of morbidity, namely blood loss, haemoglobin drop,
and overall and bleeding-related complications’ rates; (iii)
finally, in terms of oncological effectiveness, namely the
positive surgical margins rate.
After accounting for exclusion criteria (Fig. 1) [[5–9]], eligible
patients are randomised in a 1:1 ratio. After randomisation,
the two arms are defined as follows: Arm A, on-clamp LPN
(with clamping of renal artery); Arm B, off-clamp LPN (no
clamping of renal artery).
The random sequence for the treatment groups is computer
generated using the command ralloc in Stata 15 (StataCorp.,
College Station, TX, USA). Randomised allocation with a 1:1
ratio is assigned by a permuted block design, stratified by
centre. The allocation arm is notified by the study internet-
based e-form, managed by an independent software house. At
any moment, from randomisation to the end of the
procedure, the investigators are able to amend the indication
given by randomisation and shift to the alternative clamping
option, detailing the timing and the reasons of their decision.
Categorical variables are summarised as absolute and relative
frequencies, while numerical variables as mean and standard
deviations or median and interquartile range, as appropriate.
The comparison of the average estimated GFR and
haemoglobin pre- vs postoperative variations in the treatment
groups (off-clamp vs on-clamp LPN) is conducted using the
analysis of covariance (ANCOVA). The comparison of the
median values of the operative times and of the renorrhaphy
times in the study groups is performed using the non-
parametric Mann–Whitney test for independent samples. The
complications’ rates are compared by Fisher’s exact test. The
association between clinical features and the event of shift
from off-clamp to on-clamp LPN is investigated using binary
logistic regression and measured by odds ratio. All tests are
two-sided.
The outcome measurements will be analysed: (i) by intention
to treat, (ii) according to the actual treatment received, and
(iii) per protocol (participants who actually received the
treatment they were originally assigned to).
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All adverse and serious adverse events that might be related
to the study procedures are collected, fully investigated and
documented during the whole study period. An online dataset
is generated (web sites: https://www.agilegroup.it/progetti-scie
ntifici/rene/ and http://agilegroup.scientificnetwork.org/user/
login). The datasets generated and/or analysed during the
present study are available from the corresponding author on
reasonable request. The target sample size has been calculated
Patient with renal mass amenable to LPN
Screening Visit - Check of Inclusion Criteria
•     age between 18 and 80 years
•     single renal mass
•     R.E.N.A.L. score ≤ 10
•     normal coagulative function
•     eGFR* > 60 mL/min × 1.73 m2
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Renal scan
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*calculated by the CKD-EPI equation
**assessed by SIB score
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Fig. 1 The Clock II RCT flowchart. Patients demographics (body mass index, hypertension, diabetes, vascular disease, cardiac disease, comorbidities
classified according to Charlson Comorbidity Index [5] and Eastern Cooperative Oncology Group [ECOG] performance status), baseline
characteristics (tumour size, R.E.N.A.L. [Radius; Exophytic/Endophytic; Nearness; Anterior/Posterior; Location] score [6], renal scan data, serum
creatinine [SCr], estimated GFR [eGFR] – calculated by the Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI) from SCr [7],
haemoglobin [Hb] and haematocrit [Hct]), perioperative, and postoperative data are collected. The resection technique is classified by the validated
Surface-Intermediate-Base margin (SIB) score [8]. Intraoperative bleeding severity is quantified on a scale from 0 (no bleeding) to 5 (bleeding faster
than can be removed by suction); postoperative complications are classified according to the Clavien–Dindo system [9]. The surgical procedure is
determined by the study protocol and includes kidney defatting, and renal artery isolation and suspension in all patients. In the on-clamp LPN arm,
tumour resection and inner renorrhaphy are mandatorily done under ischaemia, whereas in the off-clamp arm the artery is left unclamped throughout
the entire procedure. Neither preoperative trans-arterial embolisation nor intraoperative controlled deep systemic hypotension is allowed. EBL, estimated
blood loss; POD, postoperative day; POM, postoperative month.
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using the Borm, Fransen and Lemmens formula for ANCOVA:
n ¼ ð1 q2Þ 




where n is the number for each experimental group, a the
statistical significance, 1b the power of the test, r the
standard deviation of the outcome, q the correlation between
pre- and postoperative GFR values, and d the effect size
(absolute difference of the average outcome variation in the
two experimental groups) [10].
Based on previous reports, we assumed a standard deviation
r of 20 mL/min/1.73 m2 [11]. For a = 5%, 1b = 80%, a q2
of 0.6, and a clinically significant minimum difference
d = 5 mL/min/1.73 m2, the minimum required sample size
was calculated to equal 102 patients per arm. Finally, after
adjusting for a 10% chance of dropouts, 113 patients per arm
were considered the target enrolment. The study will be
completed 24 months after the last enrollment, including a
6-, 12-, 18- and 24-month follow-up.
To the best of our knowledge, the CLOCK II study is
noteworthy because it will be the first prospective RCT
comparing the perioperative and functional outcomes of off-
clamp vs on-clamp LPN. Interestingly, the data obtained will
be cross-analysed with those of the CLOCK I randomised
study [12] comparing off-clamp to on-clamp robot-assisted
PN.
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